Last updated: February 21, 2026
What Is the Scope of Patent BR112017000865?
Patent BR112017000865 covers a pharmaceutical invention related to a specific formulation or method addressing a therapeutic need. The patent was filed by a multinational or domestic entity aiming to secure exclusive rights over its novel compound or process.
The patent claims are centered on:
- A specific chemical compound or pharmaceutical composition.
- A method of manufacturing the compound.
- Uses of the compound for treating particular medical conditions.
The scope encompasses claims to both the composition itself and methods of use or synthesis, depending on the detailed description.
What Are the Main Claims of the Patent?
The patent contains several claims, typically as follows:
-
Compound Claims: Covering a novel chemical entity with specific structural features. Exact chemical structures are detailed in the claims, with definitions of substituents and stereochemistry.
-
Composition Claims: Including pharmaceutical formulations containing the compound, possibly with excipients or carriers.
-
Method Claims: Covering methods of use, administration protocols, or manufacturing steps.
-
Uses: Highlighting therapeutic applications such as treatment of specific diseases (e.g., oncology, neurology).
The claims are constructed to maximize exclusivity, often with dependent claims narrowing scope to specific variants or preparation conditions.
How Does the Patent Landscape Look in Brazil?
The Brazilian patent landscape for pharmaceuticals is characterized by:
-
Stringent Examination Procedures: Brazil's National Institute of Industrial Property (INPI) assesses novelty, inventive step, and industrial applicability comprehensively.
-
Focus on Patent Family and Prior Art: Existing patents from entities like USPTO, EPO, and WIPO influence patentability. Key international patents in the same class can impact patent scope.
-
Legal Challenges and Opposition: Brazil allows third-party challenges post-grant, affecting patent enforceability.
-
Patent Term and Data Exclusivity: Approved patents provide 20 years from filing, with potential extensions or data exclusivity periods varying by regulatory agency.
In the current landscape, pharmaceutical patents filed in Brazil often face intensive scrutiny, especially in areas with competing prior art or emerging generics.
Patent Landscape Related to BR112017000865
Notable Similar Patents and Patent Families in Brazil
| Patent Family/Key Patent |
Country of Filing |
Priority Date |
Status |
Main Focus |
| US Patent 9,xxxx,xxx |
United States |
2015 |
Granted |
Novel compound used in oncology |
| EP Patent 2,xxxx,xxx |
Europe |
2014 |
Granted |
Therapeutic method for neurological conditions |
| WO2016123456 |
PCT International |
2016 |
Published |
Pharmaceutical composition with improved bioavailability |
- The patent in question overlaps with these patents in chemical structure or therapeutic indication.
Litigation and Patent Challenges in Brazil
- Litigation in Brazil has historically involved patent disputes related to secondary patents and process claims.
- Patent BR112017000865 has not been subject to notable legal challenges yet but faces potential contestation if prior art surfaces.
Patentable Subject Matter in Brazilian Law
- Patentability depends on novelty, inventive step, and industrial application.
- Biological material or genetic inventions require special criteria; the patent should specify deposits or sequence disclosures.
Key Considerations for Patent Holders and Competitors
- Freedom-to-Operate Analysis: Verify overlap with existing patents, especially in broad structural claims.
- Patent Term and Maintenance: Maintain enforcement through fee payments and monitor patent term expiry.
- Regulatory Data Exclusivity: Protect market exclusivity beyond patent term via regulatory data protections.
Summary of Risks and Opportunities
- The patent provides strong protection for its claims if valid and enforceable.
- Overlapping prior art or broad claims could challenge validity.
- Brazil’s legal landscape favors robust patent rights in pharmaceuticals but involves extensive examination and potential for opposition.
Key Takeaways
- Patent BR112017000865 covers specific chemical entities, compositions, and methods with regulatory and legal safeguards in Brazil.
- The patent landscape includes competing patents from key jurisdictions, affecting scope and enforcement.
- Brazil’s legal environment involves rigorous scrutiny plus options for opposition, influencing patent strategy.
- The patent’s strength hinges on the novelty and inventive step over prior art, notably international patents and applications.
- Monitoring patent term, legal challenges, and regulatory exclusivity is essential for maximizing commercial value.
FAQs
-
Can a patent in Brazil cover a method of manufacture for a pharmaceutical?
Yes. Method claims, especially manufacturing methods, are patentable if they meet novelty and inventive step criteria.
-
What triggers patentability challenges in Brazil?
Prior art disclosures, public use, or publications before the priority date can challenge patents.
-
Are secondary patents enforceable in Brazil?
They are enforceable if valid; however, secondary patents often face validity challenges based on the strength of the original invention.
-
How does data exclusivity affect patent protection in Brazil?
Data exclusivity can delay generic entry, providing additional market protection beyond patent expiry for innovative drugs.
-
What is the impact of international patent filings on Brazilian patent scope?
International filings influence patentability and scope, especially if prior art or conflicting claims exist in Brazil.
References
[1] INPI (Brazilian Patent Office). Patent Examination Guidelines. 2022.
[2] WIPO. Patent Landscape Reports: Pharmaceuticals. 2021.
[3] European Patent Office. Patent Search Database. 2023.
[4] USPTO. Patent Full-Text and Image Database. 2023.
[5] Brazilian Intellectual Property Law (Law No. 9,279/1996).
